Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Express Scripts
Johnson and Johnson
Mallinckrodt
UBS
Citi
Harvard Business School
Deloitte
Cerilliant

Generated: October 20, 2018

DrugPatentWatch Database Preview

Graham Dm Company Profile

« Back to Dashboard

What is the competitive landscape for GRAHAM DM, and what generic and branded alternatives to GRAHAM DM drugs are available?

GRAHAM DM has eighteen approved drugs.



Summary for Graham Dm
US Patents:0
Tradenames:6
Ingredients:5
NDAs:18

Drugs and US Patents for Graham Dm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Graham Dm SOMOPHYLLIN-CRT theophylline CAPSULE, EXTENDED RELEASE;ORAL 088383-001 Feb 27, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Graham Dm SOMOPHYLLIN-CRT theophylline CAPSULE, EXTENDED RELEASE;ORAL 087194-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Graham Dm PHENDIMETRAZINE TARTRATE phendimetrazine tartrate CAPSULE, EXTENDED RELEASE;ORAL 088063-001 Sep 10, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Graham Dm PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; pseudoephedrine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018843-001 Mar 18, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Graham Dm COLD CAPSULE IV chlorpheniramine maleate; phenylpropanolamine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018793-001 Apr 25, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Graham Dm PHENDIMETRAZINE TARTRATE phendimetrazine tartrate CAPSULE, EXTENDED RELEASE;ORAL 088020-001 Aug 16, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Graham Dm PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; pseudoephedrine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018844-001 Mar 20, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Citi
McKinsey
McKesson
Healthtrust
Colorcon
Accenture
UBS
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.